12:00 AM
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Deals

Galaxy, Roche deal

Galaxy granted the pharma exclusive, worldwide rights to develop and commercialize Galaxy's preclinical cancer antibodies targeting fibroblast growth...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >